BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34286351)

  • 1. Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.
    Towbin AJ; Zhang B; Dillman JR
    Pediatr Radiol; 2021 Dec; 51(13):2568-2580. PubMed ID: 34286351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective cohort evaluation of the effect of multiple administrations of gadopentetate dimeglumine on brain magnetic resonance imaging T1-weighted signal.
    Towbin AJ; Zhang B; Dillman JR
    Pediatr Radiol; 2021 Mar; 51(3):457-470. PubMed ID: 33399985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
    Invest Radiol; 2016 Nov; 51(11):683-690. PubMed ID: 27495187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and Severity of Acute Allergic-Like Reactions to Intravenously Administered Gadolinium-Based Contrast Media in Children.
    Forbes-Amrhein MM; Dillman JR; Trout AT; Koch BL; Dickerson JM; Giordano RM; Towbin AJ
    Invest Radiol; 2018 May; 53(5):313-318. PubMed ID: 29337841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
    Pozeg P; Forget J; Meuli RA; Maeder P
    Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
    Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
    Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
    Cao Y; Huang DQ; Shih G; Prince MR
    AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study.
    Topcuoglu ED; Topcuoglu OM; Semiz Oysu A; Bukte Y
    J Magn Reson Imaging; 2020 May; 51(5):1471-1477. PubMed ID: 31665554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Unenhanced T1-Weighted Signal Intensities Within the Dentate Nucleus and the Globus Pallidus After Serial Applications of Gadopentetate Dimeglumine Versus Gadobutrol in a Pediatric Population.
    Renz DM; Kümpel S; Böttcher J; Pfeil A; Streitparth F; Waginger M; Reichenbach JR; Teichgräber UK; Mentzel HJ
    Invest Radiol; 2018 Feb; 53(2):119-127. PubMed ID: 28976476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.
    Splendiani A; Perri M; Marsecano C; Vellucci V; Michelini G; Barile A; Di Cesare E
    Radiol Med; 2018 Feb; 123(2):125-134. PubMed ID: 28952018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium deposition within the paediatric brain: no increased intrinsic T1-weighted signal intensity within the dentate nucleus following the administration of a minimum of four doses of the macrocyclic agent gadobutrol.
    Young JR; Qiao J; Orosz I; Salamon N; Franke MA; Kim HJ; Pope WB
    Eur Radiol; 2018 Nov; 28(11):4882-4889. PubMed ID: 29744642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Brain: Gadolinium Deposition in Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images Is Dependent on the Type of Contrast Agent.
    Ryu YJ; Choi YH; Cheon JE; Lee WJ; Park S; Park JE; Kim WS; Kim IO
    Invest Radiol; 2018 Apr; 53(4):246-255. PubMed ID: 29300210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dentate nucleus signal intensity changes on T1-weighted MRI after repeated administrations of linear and macrocyclic gadolinium-based contrast agents: a pediatric intraindividual case-control study.
    Ozturk K; Nascene D
    Acta Radiol; 2022 Jul; 63(7):914-922. PubMed ID: 34018821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
    Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
    Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
    Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
    J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model.
    Wang ST; Hua ZX; Fan DX; Zhang X; Ren K
    Biomed Res Int; 2019; 2019():3901907. PubMed ID: 31192255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities.
    Hannoun S; Issa R; El Ayoubi NK; Haddad R; Baalbaki M; Yamout BI; Khoury SJ; Hourani R
    Acad Radiol; 2019 Oct; 26(10):e284-e291. PubMed ID: 30527456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
    Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
    Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal Intensity Evaluation in the Dentate Nucleus and Subcortical Gray Matter : Effect of Several Administrations of Gadoterate Meglumine in Multiple Sclerosis.
    Hannoun S; Kocevar G; Codjia P; Maucort-Boulch D; Cotton F; Vukusic S; Durand-Dubief F; Sappey-Marinier D
    Clin Neuroradiol; 2022 Sep; 32(3):677-685. PubMed ID: 33630120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.